In this study, we investigated that a decreased DRAK1 protein stability followed by upregulation of TRAF6 levels, and TRAF6-mediated NF-κB signaling pathway, promotes the malignancy of paclitaxel-resistant cervical cancer cells. This evidence concerns the gene NFKB1 and cervical carcinoma.